---
figid: PMC5658232__10-1055-s-0043-118907-i4337655gf01
figtitle: PI3K/Akt/mTor pathway and effects of mTOR-inhibitors
organisms:
- NA
pmcid: PMC5658232
filename: 10-1055-s-0043-118907-i4337655gf01.jpg
figlink: /pmc/articles/PMC5658232/figure/FI4337655-1/
number: F1
caption: PI3K/Akt/mTor pathway and effects of mTOR-inhibitors. Different signaling
  cascades have been shown to modulate mammalian target of rapamycin (mTOR). Growth
  factor mediated intracellular signaling triggered PDPK1 to phosphorylate and activate
  PKB/AKT. AKT directly phospho-inhibited TSC2 which consequently resulted in activation
  of mTOR via RHEB resulting in phosphorylation of protein S6 kinase beta-1 (S6K1).
  Newer treatment strategies should focus on inhibition of mTORC1 and mTORC2 multi-proteins
  assemblies and on treatments that combine mTOR inhibitors with different interconnected
  pathway inhibitors.
papertitle: 'PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right
  Track?.'
reftext: Maria Luisa Gasparri, et al. Geburtshilfe Frauenheilkd. 2017 Oct;77(10):1095-1103.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9597151
figid_alias: PMC5658232__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5658232__F1
ndex: b4555020-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5658232__10-1055-s-0043-118907-i4337655gf01.html
  '@type': Dataset
  description: PI3K/Akt/mTor pathway and effects of mTOR-inhibitors. Different signaling
    cascades have been shown to modulate mammalian target of rapamycin (mTOR). Growth
    factor mediated intracellular signaling triggered PDPK1 to phosphorylate and activate
    PKB/AKT. AKT directly phospho-inhibited TSC2 which consequently resulted in activation
    of mTOR via RHEB resulting in phosphorylation of protein S6 kinase beta-1 (S6K1).
    Newer treatment strategies should focus on inhibition of mTORC1 and mTORC2 multi-proteins
    assemblies and on treatments that combine mTOR inhibitors with different interconnected
    pathway inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDPK1
  - IRS1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - RPS6KB1
  - TSC1
  - CCL26
  - RPTOR
  - TSC2
  - RHEB
  - RHEBP1
---
